Diversified · Founded 1935 · www.gillandersarbuthnot.com · BSE 532716 · NSE GILLA ARBUT · ISIN INE047B01011
No Notes Added Yet
Business
Gillanders Arbuthnot & Company Ltd. is an old Indian diversified conglomerate with operations spanning multiple sectors. Its core businesses include the cultivation and processing of Tea, manufacturing of Textiles (spinning cotton, polyester, and blended yarns), production of Engineering goods (primarily railway components), and manufacturing of various Chemicals (plasticizers, specialty chemicals). The company also has a smaller Property division managing its real estate assets. It generates revenue by selling its manufactured and cultivated products to industrial and consumer markets.
Revenue Mix
The company's major business segments include:
Tea: Cultivation, manufacturing, and sale of CTC tea, primarily from its gardens in Assam and Dooars.
Textile: Manufacturing and sale of various types of yarns to domestic and international markets.
Engineering: Production and supply of components, largely for the Indian railway sector.
Chemicals: Manufacturing and sale of industrial chemicals such as plasticizers and specialty chemicals.
Property & Investment: Rental income from properties and returns from investments.
The revenue contribution from these segments varies depending on market conditions and commodity cycles, but Tea and Textiles generally form significant parts of its top line, complemented by Engineering and Chemicals.
Industry
Gillanders Arbuthnot operates across several distinct industries:
Tea: Part of the competitive Indian tea industry, susceptible to weather patterns and global prices. It's a mid-sized player with established estates.
Textile (Yarn): Operates in the fragmented Indian textile spinning industry, which is raw material price sensitive and influenced by export demand.
Engineering (Railway Spares): Engaged in a niche within the Indian railway ecosystem, dependent on government infrastructure spending and railway modernization.
Chemicals: Produces specialty chemicals for various industrial end-users, facing competition from domestic and international players.
The company is not a market leader in any single segment but rather a participant with an established presence and asset base across these varied sectors.
MOAT
The company's primary advantages include:
Legacy & Established Relationships: With over a century of operation, it benefits from a long-standing brand name and established relationships with customers, suppliers, and distributors across its diverse businesses.
Asset Base: Ownership of tea estates, manufacturing facilities (textiles, engineering, chemicals), and real estate provides a tangible asset base.
Diversification: Its presence across multiple, often uncorrelated, business segments helps to mitigate risk by providing stability against downturns in any single industry.
Niche Expertise: In certain areas like specific railway components or specialty chemicals, the company may possess specialized manufacturing capabilities or certifications, creating some customer stickiness.
However, strong, scalable economic moats like dominant brand equity, significant economies of scale across all segments, or network effects are less apparent, as most of its industries are highly competitive and prone to commodity cycles.
Growth Drivers
Indian Infrastructure Development: Continued investment in railway modernization and expansion will drive demand for its engineering products.
Domestic Consumption Growth: Rising disposable incomes and population growth in India can boost demand for tea and textile products.
Industrial Growth: Expansion of end-user industries (e.g., plastics, construction, automotive) will increase demand for its specialty chemicals and plasticizers.
Operational Efficiency: Focus on improving agricultural yields in tea, optimizing textile manufacturing processes, and cost management can enhance profitability.
Value-Added Products: Potential to shift towards higher-margin, value-added products within its textile, chemical, or even tea segments.
Risks
Commodity Price Volatility: Fluctuations in prices of tea, cotton, and chemical raw materials directly impact profitability.
Climate & Monsoon Risk: The tea business is highly dependent on favorable weather conditions, making it vulnerable to climate change and erratic monsoons.
Labor & Regulatory Risks: High labor dependency in tea and textiles, coupled with complex environmental and labor regulations across all segments, poses compliance and cost risks.
Industry Cyclicality: Its textile, engineering, and chemical segments are cyclical, making the company susceptible to economic downturns.
Intense Competition: All its segments operate in competitive landscapes, which can pressure margins and market share.
Challenges of Diversification: Managing a diverse portfolio of businesses, each with distinct market dynamics and capital requirements, can be complex and may lead to sub-optimal resource allocation.
Management & Ownership
Gillanders Arbuthnot & Company Ltd. is part of the Kothari Group. The promoter group (Kothari family) holds a significant majority stake in the company, ensuring strong management control and alignment of long-term interests. The management team comprises experienced professionals, reflecting stability and a long history of navigating diverse industrial landscapes. The high promoter holding is characteristic of many established Indian conglomerates.
Outlook
Gillanders Arbuthnot & Company Ltd. benefits from its long-established presence, diversified revenue base, and significant asset ownership, which collectively contribute to operational stability. Its exposure to fundamental Indian consumption and industrial sectors provides a foundational demand base. However, the company operates in mature and highly competitive industries where profitability is often influenced by external factors such as commodity price volatility, climatic conditions, and government policies. While its diversification mitigates risk from any single segment, it also presents challenges in achieving aggressive growth or market leadership across all its disparate businesses. The company's future performance will largely hinge on its ability to sustain operational efficiencies, effectively manage cost pressures, prudently allocate capital towards strategic growth opportunities, and navigate the inherent cyclicality and competitive pressures within its varied portfolio.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 69 | 85 | 127 | 128 | 104 | 88 | 132 | 107 | 103 | 91 |
| Other Income | -1 | 2 | 4 | 1 | 4 | 0 | 3 | 3 | 6 | 2 |
| Total Income | 68 | 87 | 130 | 129 | 108 | 89 | 135 | 110 | 109 | 93 |
| Total Expenditure | 84 | 90 | 101 | 120 | 106 | 88 | 113 | 99 | 108 | 85 |
| Operating Profit | -17 | -4 | 29 | 9 | 2 | 0 | 22 | 11 | 1 | 8 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 12 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -22 | -10 | 23 | 15 | -4 | -6 | 16 | 5 | -5 | 2 |
| Provision for Tax | 2 | 0 | 2 | 2 | -6 | -0 | 2 | 1 | -1 | -0 |
| Profit After Tax | -25 | -10 | 21 | 13 | 2 | -5 | 14 | 5 | -4 | 3 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Profit After Adjustments | -25 | -10 | 21 | 13 | 2 | -5 | 14 | 5 | -4 | 3 |
| Adjusted Earnings Per Share | -11.6 | -4.6 | 10.1 | 6.1 | 1 | -2.6 | 6.7 | 2.1 | -1.8 | 1.2 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 820 | 681 | 665 | 751 | 660 | 431 | 406 | 449 | 363 | 443 | 431 | 433 |
| Other Income | 11 | 12 | 21 | 12 | 17 | 9 | 17 | 20 | 14 | 11 | 12 | 14 |
| Total Income | 830 | 693 | 685 | 763 | 677 | 440 | 424 | 469 | 377 | 454 | 442 | 447 |
| Total Expenditure | 813 | 658 | 615 | 686 | 632 | 400 | 377 | 437 | 397 | 417 | 408 | 405 |
| Operating Profit | 17 | 35 | 70 | 77 | 45 | 40 | 47 | 32 | -20 | 36 | 35 | 42 |
| Interest | 51 | 54 | 50 | 50 | 48 | 37 | 23 | 18 | 14 | 12 | 13 | 12 |
| Depreciation | 19 | 22 | 24 | 20 | 20 | 16 | 12 | 12 | 12 | 11 | 11 | 11 |
| Exceptional Income / Expenses | 0 | 22 | 0 | 0 | 10 | -2 | 0 | 11 | 0 | 12 | 0 | 0 |
| Profit Before Tax | -53 | -18 | -4 | 7 | -12 | -15 | 11 | 12 | -46 | 25 | 11 | 18 |
| Provision for Tax | 2 | 1 | 5 | 6 | 3 | 0 | -5 | -3 | 3 | -2 | 2 | 2 |
| Profit After Tax | -55 | -19 | -9 | 0 | -15 | -16 | 16 | 15 | -49 | 27 | 9 | 18 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -55 | -19 | -9 | 0 | -15 | -16 | 16 | 15 | -49 | 27 | 9 | 18 |
| Adjusted Earnings Per Share | -25.9 | -8.8 | -4 | 0.2 | -7.1 | -7.3 | 7.7 | 6.9 | -22.8 | 12.5 | 4.4 | 8.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -3% | -1% | 0% | -6% |
| Operating Profit CAGR | -3% | 3% | -3% | 7% |
| PAT CAGR | -67% | -16% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -3% | 4% | 17% | 7% |
| ROE Average | 4% | -1% | 1% | -4% |
| ROCE Average | 6% | 3% | 4% | 5% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 178 | 284 | 292 | 289 | 276 | 253 | 270 | 277 | 217 | 245 | 258 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 216 | 196 | 166 | 151 | 113 | 77 | 69 | 38 | 30 | 26 | 34 |
| Other Non-Current Liabilities | 24 | 22 | 18 | 27 | 29 | 24 | 19 | 15 | 42 | 32 | 34 |
| Total Current Liabilities | 447 | 444 | 476 | 468 | 449 | 281 | 249 | 228 | 197 | 219 | 237 |
| Total Liabilities | 865 | 945 | 952 | 935 | 867 | 634 | 607 | 558 | 486 | 522 | 562 |
| Fixed Assets | 310 | 441 | 432 | 427 | 421 | 315 | 312 | 298 | 263 | 256 | 253 |
| Other Non-Current Assets | 101 | 61 | 78 | 73 | 53 | 38 | 38 | 30 | 35 | 55 | 61 |
| Total Current Assets | 454 | 443 | 442 | 435 | 393 | 281 | 258 | 230 | 189 | 211 | 249 |
| Total Assets | 865 | 945 | 952 | 935 | 867 | 634 | 607 | 558 | 486 | 522 | 562 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 21 | 23 | 22 | 2 | 3 | 4 | 2 | 1 | 3 | 2 | 1 |
| Cash Flow from Operating Activities | 40 | 47 | 69 | 102 | 73 | 68 | 69 | 48 | 33 | 8 | 14 |
| Cash Flow from Investing Activities | -8 | 41 | -14 | -18 | 1 | 108 | -2 | 11 | -3 | -7 | -8 |
| Cash Flow from Financing Activities | -30 | -83 | -74 | -82 | -73 | -178 | -68 | -57 | -30 | -3 | -4 |
| Net Cash Inflow / Outflow | 3 | 5 | -20 | 1 | 1 | -2 | -1 | 2 | -0 | -2 | 2 |
| Closing Cash & Cash Equivalent | 24 | 28 | 2 | 3 | 4 | 2 | 1 | 3 | 2 | 1 | 3 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -25.94 | -8.83 | -4.01 | 0.15 | -7.13 | -7.32 | 7.66 | 6.95 | -22.78 | 12.52 | 4.44 |
| CEPS(Rs) | -17.07 | 1.51 | 7.34 | 9.63 | 2.08 | 0.19 | 13.49 | 12.55 | -17.27 | 17.61 | 9.55 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 82.49 | 132.98 | 136.8 | 135.46 | 129.3 | 118.37 | 126.44 | 129.69 | 101.89 | 114.88 | 120.86 |
| Core EBITDA Margin(%) | 0.8 | 3.44 | 7.47 | 8.7 | 4.31 | 7.09 | 7.31 | 2.65 | -9.21 | 5.78 | 5.41 |
| EBIT Margin(%) | -0.2 | 5.19 | 6.92 | 7.62 | 5.34 | 5.02 | 8.53 | 6.7 | -8.7 | 8.4 | 5.56 |
| Pre Tax Margin(%) | -6.42 | -2.66 | -0.61 | 0.9 | -1.89 | -3.54 | 2.82 | 2.7 | -12.61 | 5.62 | 2.56 |
| PAT Margin (%) | -6.7 | -2.77 | -1.29 | 0.04 | -2.31 | -3.63 | 4.01 | 3.29 | -13.32 | 6.01 | 2.19 |
| Cash Profit Margin (%) | -4.41 | 0.47 | 2.36 | 2.74 | 0.67 | 0.1 | 7.07 | 5.94 | -10.1 | 8.46 | 4.72 |
| ROA(%) | -5.98 | -2.08 | -0.9 | 0.03 | -1.69 | -2.08 | 2.63 | 2.54 | -9.31 | 5.3 | 1.74 |
| ROE(%) | -28.75 | -8.2 | -2.98 | 0.11 | -5.39 | -5.91 | 6.25 | 5.42 | -19.68 | 11.55 | 3.76 |
| ROCE(%) | -0.25 | 5.1 | 6.35 | 8.19 | 5.33 | 3.86 | 7.46 | 6.92 | -8.27 | 10.22 | 6.08 |
| Receivable days | 57.66 | 61.64 | 54.52 | 47.27 | 49.54 | 61.5 | 46.26 | 26.63 | 27.76 | 37.44 | 52.78 |
| Inventory Days | 71.21 | 86.43 | 94.9 | 90.47 | 95.6 | 108.81 | 98.85 | 92.62 | 100.23 | 76.25 | 83.71 |
| Payable days | 89.27 | 138.19 | 168.95 | 159.99 | 174.63 | 234.56 | 217.28 | 157.47 | 162.67 | 124.3 | 179.84 |
| PER(x) | 0 | 0 | 0 | 322.58 | 0 | 0 | 8.52 | 8.93 | 0 | 7.69 | 18.22 |
| Price/Book(x) | 0.74 | 0.49 | 0.45 | 0.36 | 0.15 | 0.37 | 0.52 | 0.48 | 0.72 | 0.84 | 0.67 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.74 | 0.85 | 0.82 | 0.65 | 0.58 | 0.72 | 0.78 | 0.61 | 0.78 | 0.78 | 0.74 |
| EV/Core EBITDA(x) | 35.15 | 16.36 | 7.79 | 6.29 | 8.41 | 7.82 | 6.74 | 8.67 | -14.15 | 9.48 | 9.09 |
| Net Sales Growth(%) | -6.37 | -16.91 | -2.38 | 12.99 | -12.13 | -34.74 | -5.65 | 10.49 | -19.1 | 21.99 | -2.78 |
| EBIT Growth(%) | -105.64 | 2203.91 | 30 | 24.39 | -38.44 | -38.59 | 60.69 | -13.04 | -205.02 | 217.59 | -35.57 |
| PAT Growth(%) | -523.59 | 65.94 | 54.56 | 103.78 | -4795.96 | -2.66 | 204.58 | -9.29 | -428.03 | 154.96 | -64.58 |
| EPS Growth(%) | -523.6 | 65.94 | 54.56 | 103.78 | -4794.67 | -2.66 | 204.58 | -9.29 | -428.03 | 154.96 | -64.58 |
| Debt/Equity(x) | 2.68 | 1.58 | 1.45 | 1.35 | 1.33 | 0.9 | 0.68 | 0.52 | 0.59 | 0.57 | 0.58 |
| Current Ratio(x) | 1.02 | 1 | 0.93 | 0.93 | 0.88 | 1 | 1.03 | 1.01 | 0.96 | 0.96 | 1.05 |
| Quick Ratio(x) | 0.65 | 0.64 | 0.54 | 0.53 | 0.52 | 0.65 | 0.54 | 0.54 | 0.48 | 0.54 | 0.6 |
| Interest Cover(x) | -0.03 | 0.66 | 0.92 | 1.13 | 0.74 | 0.59 | 1.49 | 1.68 | -2.22 | 3.02 | 1.85 |
| Total Debt/Mcap(x) | 3.65 | 3.24 | 3.22 | 3.74 | 9.04 | 2.44 | 1.32 | 1.09 | 0.83 | 0.68 | 0.86 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.08 | 69.08 | 69.08 | 69.08 | 69.21 | 69.05 | 69.05 | 69.05 | 69.05 | 69.05 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 |
| Public | 30.57 | 30.57 | 30.57 | 30.57 | 30.44 | 30.6 | 30.6 | 30.6 | 30.6 | 30.6 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.47 | 1.47 | 1.47 | 1.47 | 1.48 | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -3% | -1% | 0% | -6% |
| Operating Profit CAGR | -3% | +3% | -3% | +7% |
| PAT CAGR | -67% | -16% | — | — |
| Share Price CAGR | -3% | +4% | +17% | +7% |
| ROE Average | +4% | -1% | +1% | -4% |
| ROCE Average | +6% | +3% | +4% | +5% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.08 | 69.08 | 69.08 | 69.08 | 69.21 | 69.05 | 69.05 | 69.05 | 69.05 | 69.05 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 |
| Public | 30.57 | 30.57 | 30.57 | 30.57 | 30.44 | 30.6 | 30.6 | 30.6 | 30.6 | 30.6 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.47 | 1.47 | 1.47 | 1.47 | 1.48 | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.